Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders

Keyphrases

• Hematopoietic Stem Cells 100%
• Genome Editing 100%
• Homology-directed Repair 100%
• Inborn Errors of Immunity 100%
• Immunological Disorders 100%
• Blood Disorders 100%
• Gene Therapy 75%
• Blood System 50%
• Cas9 Protein 50%
• Gene Knockout 50%
• Therapy Research 25%
• Clinical Application 25%
• Immune System 25%
• Potential Treatments 25%
• CD34+ 25%
• Existing Problems 25%
• Non-homologous End Joining 25%
• OR Genes 25%
• Genetic Engineering 25%
• Lentiviral 25%
• Gene Correction 25%
• Immunity System 25%
• System Disorders 25%
• Gene Addition 25%
• Prime Editing 25%
• Base Editing 25%
• Targeted nuclease 25%

Immunology and Microbiology

• Primary Immunodeficiency 100%
• CRISPR/Cas9 100%
• Gene Editing 100%
• Nuclease 50%
• Solution and Solubility 50%
• Immune System 50%
• CD34 50%
• Genome Editing 50%
• DNA End Joining Repair 50%
• Gene Knock-In 50%
• Transgene 50%
• Gene Knockout 50%

Biochemistry, Genetics and Molecular Biology

• Gene Therapy 100%
• Genome Editing 100%
• Progenitor Cell 100%
• CRISPR/Cas9 66%
• Solution and Solubility 33%
• Genome Editing 33%
• Transgene 33%
• CD34 33%
• Non-Homologous End Joining 33%
• Nuclease 33%
• Gene Knockout 33%
• Gene Knockin 33%